New screening study aims to catch deadly pancreatic cancer early in High-Risk individuals
NCT ID NCT02478892
Summary
This study is testing whether regular screening with MRI or a special ultrasound can help find early pancreatic cancer or pre-cancerous changes in people who have a high inherited risk due to specific gene mutations (BRCA1, BRCA2, ATM, or PALB2). Researchers will follow 200 participants over time to see if these screening methods are practical and effective for this group. The goal is to detect problems early when they might be more treatable, potentially improving survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Abramson Cancer Center of the University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19004, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.